The United States has secured approximately 333 million doses of an experimental COVID-19 vaccine. The US Department of Health and Human Services pledged up to $1.2 billion to accelerate AstraZeneca’s vaccine development.
The use of the vaccine is unclear as of now because there is uncertainty surrounding immunity to COVID, however, the pledge is intended to potentially kickstart the US economy.
The US could potentially have the first doses as early as October according to the Department of Health and Human Services.